Management of infections caused by respiratory syncytial virus

Scandinavian Journal of Infectious Diseases

Volumn 33, Issue 5, 2001, Pages 323-328

  Ahlqvist Rastad, A ^a   Andersson, J ^a   Beermann, B ^a   Bohlin, A B ^a   Brandt, C ^a   Eriksson, M ^a   Ewald, U ^a   Gothberg, S ^a   Lind, A ^a   Lindroth, M ^a   Ljungman, P ^a   Naver L ^a   Norrby, S R ^a  

^a Swedish Inst Infec Dis Ctrl   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; MONOCLONAL ANTIBODY; OXYGEN; PALIVIZUMAB; POLYCLONAL ANTIBODY; REPSIGAM; RIBAVIRIN; STEROID; VIRUS VACCINE;

AEROSOL; AGE; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CHILD; CONJUNCTIVITIS; DISEASE COURSE; DISEASE SEVERITY; DRUG BIOAVAILABILITY; DRUG EXCRETION; DRUG HALF LIFE; DRUG INDICATION; EVIDENCE BASED MEDICINE; FEVER; GESTATIONAL AGE; GRAFT REJECTION; HEADACHE; HIGH RISK PATIENT; HUMAN; INFANT; INFECTION PREVENTION; INJECTION SITE; LARYNGITIS; MEDICAL DOCUMENTATION; NERVOUSNESS; ORGAN TRANSPLANTATION; PNEUMONIA; RASH; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; SIDE EFFECT; STEM CELL TRANSPLANTATION; SWEDEN; SYMPTOM; TERATOGENICITY; VIRUS INFECTION;

AGED; ANTIBODIES, MONOCLONAL; ANTIVIRAL AGENTS; CHILD, PRESCHOOL; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT; INFANT, NEWBORN; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; RIBAVIRIN;

EID: 17844364476     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655401750173869     Document Type: Article

References (24)

1. Pediatric Investigators Collaborative Network of Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection
2. Acute lower respiratory illness in elderly patients with respiratory syncytial virus infection
3. Ribavirin for respiratory syncytial virus infection of the lower respiratory tract
4. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants
5. Skall vi aldrig säga nej? Till exempel till RSV-profylax
6. Cost-effectiveness of respiratory syncytial virus prophylaxis among preterm infants
7. Respiratory syncytial virus: A continuing culprit and conundrun
8. RS-virusinfektion vanligaste enskilda orsaken till sjukhusvård hos barn. Profylax vid hög risk önskvärd men lokal epidemiologi bör avgöra
9. Regular pattern of respiratory syncytial virus and rotavirus infections and relation to weather in Stockholm, 1984-1994
10. Respiratory syncytial virus-Missouri
11. Respiratory syncytial virus infection
12. Respiratory syncytial virus infection in infants with congenital heart disease
13. Rehospitalization because of respiratory syncytial virus infection in premature infants younger than 33 weeks of gestation: A prospective study
14. Respiratory syncytial virus and subsequent lower respiratory tract infections in developing countries: A new twist to an old virus
15. Prevention and treatment recommendations for respiratory syncytial virus infection. Background and clinical experience 40 years after discovery
16. Respiratory syncytial virus infection in the elderly
17. Prevention strategies for respiratory syncytial virus: Passive and active immunization
18. Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis
19. Ribavirin for respiratory syncytial virus lower respiratory tract infection: A systematic overview
20. A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection
21. Community respiratory virus infections among hospitalized adult bone marrow transplant recipients
22. Respiratory syncytial virus immune globulin treatment of lower respiratory tract infection in pediatric patients undergoing bone marrow transplantation - A compassionate use experience
23. Phase I study of intravenous ribavirin treatment of respiratory syncytial virus pneumonia after marrow transplantation
24. Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections